Acceptability and Feasibility of Sexually Transmitted Infection Testing and Treatment among Pregnant Women in Gaborone, Botswana, 2015

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Wynn, Adriane ^a   Ramogola Masire, Doreen ^b,c   Gaolebale, Ponatshego ^d   Moshashane, Neo ^c   Agatha Offorjebe, Ogechukwu ^e,f   Arena, Kaitlin ^f   Klausner, Jeffrey D ^f   Morroni, Chelsea ^b,g,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOTSWANA UPENN PARTNERSHIP   (Botswana)

^c UNIVERSITY OF BOTSWANA   (Botswana)

^d PRINCESS MARINA HOSPITAL   (Botswana)

^e CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; METRONIDAZOLE;

ADULT; ARTICLE; BOTSWANA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DEMOGRAPHY; DIAGNOSTIC KIT; FEMALE; GESTATIONAL AGE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NEISSERIA GONORRHOEAE; PATIENT ATTITUDE; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; PROGRAM ACCEPTABILITY; PROGRAM FEASIBILITY; PUBLIC HOSPITAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; TREATMENT RESPONSE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINAL SWAB; ADOLESCENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTOR; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; BOTSWANA; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; NEISSERIA GONORRHOEAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; YOUNG ADULT;

EID: 84971402164     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/1251238     Document Type: Article

References (34)

1. World Health Organization, Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008, World Health Organization, Geneva, Switzerland, 2012.
2. Institute ofMedicine, Preterm Birth: Causes, Consequences, and Prevention, Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 2007.
3. M. F. Silveira, K. G. Ghanem, E. J. Erbelding et al., "Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: A case-control study, " International Journal of STD and AIDS, vol. 20, no. 7, pp. 465-469, 2009.
4. P. Claman, B. Toye, R. W. Peeling, P. Jessamine, and J. Belcher, "Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth, " Canadian Medical Association Journal, vol. 153, no. 3, pp. 259-262, 1995.
5. M. Gencay, M. Koskiniemi, P. Ämmälä et al., "Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery, " APMIS, vol. 108, no. 9, pp. 584-588, 2000.
6. M. F. Cotch, J. G. Pastorek II, R. P. Nugent et al., "Trichomonas vaginalis associated with lowbirthweight and pretermdelivery, " Sexually Transmitted Diseases, vol. 24, no. 6, pp. 353-360, 1997.
7. G. I. J. G. Rours, R. R. de Krijger, A. Ott et al., "Chlamydia trachomatis and placental inflammation in early pretermdelivery, " European Journal of Epidemiology, vol. 26, no. 5, pp. 421-428, 2011.
8. L. F. Johnson and D. A. Lewis, "The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis, " Sexually Transmitted Diseases, vol. 35, no. 11, pp. 946-959, 2008.
9. W. Fawzi, G. Msamanga, B. Renjifo et al., "Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women, " AIDS, vol. 15, no. 9, pp. 1157-1165, 2001.
10. C. C. Bristow, "Syndromic diagnostic approaches togenitourinary tract infections, " in Molecular Microbiology: Diagnostic Principles and Practice, American Society for Microbiology Press, 3rd edition, 2015.
11. Public Health Agency of Canada, Report on Sexually Transmitted Infections in Canada: 2010, PublicHealth Agency of Canada, 2012.
12. D. S. LaMontagne, K. A. Fenton, S. Randall, S. Anderson, and P. Carter, "Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening, " Sexually Transmitted Infections, vol. 80, no. 5, pp. 335-341, 2004.
13. U. S. Preventive Services Task Force, "Screening for chlamydial infection: U. S. preventive services task force recommendation statement, " Annals of Internal Medicine, vol. 147, no. 2, pp. 128-134, 2007.
14. N. Low, "Publication of report on chlamydia control activities in Europe, " Euro Surveillance, vol. 13, no. 28, 2008.
15. T. M. Weissenbacher, M. S. Kupka, F. Kainer, K. Friese, and I. Mylonas, "Screening for Chlamydia trachomatis in pregnancy: A retrospective analysis in a German urban area, " Archives of Gynecology and Obstetrics, vol. 283, no. 6, pp. 1343-1347, 2011.
16. K. A. Workowski and S. Berman, "Sexually transmitted diseases treatment guidelines, 2010, " MMWR Recommendations and Reports, vol. 59, no. RR12, pp. 1-110, 2010.
17. World Health Organization, Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006-2015, 2007, http://www. who. int/hiv/pub/toolkits/stis strategy[1]en. pdf.
18. P. Mayaud and D. Mabey, "Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges, " Sexually Transmitted Infections, vol. 80, no. 3, pp. 174-182, 2004.
19. Centers for Disease Control and Prevention, "Trichomoniasis-CDCFact Sheet, " 2015, http://www. cdc. gov/std/trichomonas/ stdfact-trichomoniasis. htm.
20. T. A. Farley, D. A. Cohen, and W. Elkins, "Asymptomatic sexually transmitted diseases: The case for screening, " Preventive Medicine, vol. 36, no. 4, pp. 502-509, 2003.
21. E. L. Korenromp, M. K. Sudaryo, S. J. De Vlas et al., "What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic" International Journal of STD and AIDS, vol. 13, no. 2, pp. 91-101, 2002.
22. R. Platt, P. A. Rice, and W. M. McCormack, "Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea, " The Journal of the American Medical Association, vol. 250, no. 23, pp. 3205-3209, 1983.
23. M. Romoren, M. Rahman, J. Sundby, and P. Hjortdahl, "Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana, " Sexually Transmitted Infections, vol. 80, no. 5, pp. 395-400, 2004.
24. M. Romoren, M. Velauthapillai, M. Rahman, J. Sundby, E. Klouman, and P. Hjortdahl, "Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach, " Bulletin of theWorldHealthOrganization, vol. 85, no. 4, pp. 297-304, 2007.
25. J. Y. Chen, A. C. Ogwu, P. Svab et al., "Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4+ cell counts in Gaborone, Botswana, " Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 1, pp. 102-106, 2010.
26. C. A. Gaydos, B. Van Der Pol, M. Jett-Goheen et al., "Performance of the cepheid CT/NGXpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae, " Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1666-1672, 2013.
27. C. A. Gaydos, "Review of use of a new rapid real-time PCR, the Cepheid GeneXpert- (Xpert) CT/NG assay, for Chlamydia trachomatis andNeisseria gonorrhoeae: results for patientswhile in a clinical setting, " Expert ReviewofMolecularDiagnostics, vol. 14, no. 2, pp. 135-137, 2014.
28. S. G. Badman, L. M. Causer, R. Guy et al., "Rapid laboratory assessment of a new [Gx] GeneXpert molecular point-of-care test for detection of Trichomonas vaginalis, " in Proceedings of the Australasian Sexual Health Conference, Sydney, Australia, 2014.
29. J. Cabeza, P. J. García, E. Segura et al., "Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: A prospective study in two large urban hospitals, " Sexually Transmitted Infections, vol. 91, pp. 7-10, 2015.
30. N. Bourgeois-Nicolaos, F. Jaureguy, S. Pozzi-Gaudin et al., "Benefits of rapid molecular diagnosis of Chlamydia trachomatis andNeisseria gonorrhoeae infections inwomen attending family planning clinics, " Sexually Transmitted Diseases, vol. 42, no. 11, pp. 652-653, 2015.
31. M. Romoren, J. Sundby, M. Velauthapillai, M. Rahman, E. Klouman, and P. Hjortdahl, "Chlamydia and gonorrhoea in pregnant Batswana women: Time to discard the syndromic approach" BMC Infectious Diseases, vol. 7, article 27, 2007.
32. R. M. Chico, P. Mayaud, C. Ariti, D. Mabey, C. Ronsmans, and D. Chandramohan, "Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: A systematic review, " The Journal of the American Medical Association, vol. 307, no. 19, pp. 2079-2086, 2012.
33. Statistics Botswana NACA and Ministry of Health, Botswana AIDS Impact Survey 2013 (BAIS IV 2013), http://1govportal . imexsystems. net/en-gb/Documents/Ministry%20of%20State %20President/NACA/Botswana%20AIDS%20Impact%20Survey %20IV%20Report. pdf.
34. M. Romoren, F. Hussein, T. W. Steen et al., "Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa, " Sexually Transmitted Infections, vol. 83, no. 7, pp. 558-566, 2007.